L&G Pharma Breakthrough ETF (LSE:BIOT) - ETF price


ETF Report

L&G Pharma Breakthrough UCITS ETF BIOT

Closing Price
USD9.08

1 Day Change
-0.04|-0.44%

As of 18/10/2019

Last Close9.08
52-Wk Range8.87 - 10.44
Yield %0.00
ISINIE00BF0H7608
Volume26,110
Premium %0.35

Growth Of 10,000 (USD) 30/09/2019

HowHasThisSecurityPerformed
201420152016201720182019
Fund------3.39
Category-----3.25
Benchmark-----3.21
  • Fund: L&G Pharma Breakthrough UCITS ETF
  • Category: Sector Equity Biotechnology
  • Benchmark: NASDAQ Biotechnology TR USD
Trailing Returns % (USD) 18/10/2019
FundCatBmark
YTD0.008.436.05
3 Years Annualised---
5 Years Annualised---
10 Years Annualised---
Key Stats
Morningstar® CategorySector Equity Biotechnology
ISINIE00BF0H7608
NAV 18/10/2019USD 9.08
Day Change-0.44%
12 Month Yield0.00%
Dividend Frequency-
Net Assets (mil) 18/10/20197.23 USD
Total Expense Ratio0.75%
Initial Charge-
Exit Charge-
Manager Name-
Inception Date18/01/2018

Morningstar Rating™

Not Rated

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Benchmarks

Fund Benchmark

Solactive Pharma Breakthrough V NR USD

Morningstar® Benchmark

NASDAQ Biotechnology TR USD

Investment Objective

The objective of the fund is to provide exposure to a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The Index selects stocks that meet certain size and liquidity requirements using a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts.

Portfolio Profile18/10/2019

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
Mallinckrodt PLC Healthcare5.00
Ligand Pharmaceuticals Inc Healthcare4.20
Ipsen SA Healthcare3.90
BeiGene Ltd ADR Healthcare3.86
Celgene Corp Healthcare3.76
Asset Allocation %
LongShortNet
Stocks100.010.00100.01
Bonds0.000.000.00
Cash0.000.01-0.01
Other0.000.000.00
Top Stock Regions
Region%
United States63.95
Japan10.88
Europe - ex Euro10.26
Eurozone7.38
Asia - Emerging3.86
Top Stock Sectors
Stock Sectors%
Healthcare100.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.